Search for Clinical Trial Results

Sponsored By

Heart Defects, Congenital - 26 Studies Found

Status Study
Terminated Study Name: Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery
Condition: Heart Defects, Congenital
Date: 2007-10-10
Interventions:
  • Drug: nesiritide Nesiritide bo
Completed Study Name: Physical Activity in Fontan Patients
Condition: Heart Defects, Congenital
Date: 2006-08-10
Interventions:
  • Behavioral: Physical Activity

Terminated Study Name: Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease
Condition: Congenital Heart Defects
Date: 2005-09-13
Completed Study Name: Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease
Condition: Heart Defects, Congenital
Date: 2012-08-31
Interventions: Other: measuring cerebral oxygenation
Not yet recruiting Study Name: Xeltis Bioabsorbable Pulmonary Valved Conduit Early Feasibility Study
Condition: Heart Defect, Congenital
Date: 2017-01-10
Interventions: Device: Xeltis Bioabsorbable Pulmonary Valved Conduit Surgical implantation of Xeltis Bioabsorbable Pulm
Withdrawn Study Name: Tranexamic Acid Effect on Platelet Aggregation Following Infant Cardiopulmonary Bypass
Condition: Heart Defect, Congenital
Date: 2014-04-23
Interventions:
  • Drug: Tranexamic Acid
  • Drug: placebo
Enrolling by invitation Study Name: CTICU Pacifier Activated Music Player and Mother's Voice
Condition: Heart Defects, Congenital
Date: 2017-01-23
Interventions: Behavioral: Pacifier activated music player Therefore the immediate goal of the current proposal is to d
Completed Study Name: The Fontan Education Study: A Randomized Control Trial
Condition: Heart Defects, Congenital
Date: 2016-07-11
Interventions: Other: Fontan Education Videos The intervention will consi
Completed Study Name: Right Lateral Positioning of Postoperative Pediatric Cardiac Surgery
Condition: Heart Defects, Congenital
Date: 2015-11-28
Interventions:
  • Procedure: Right lateral position (2 hours)

Terminated Study Name: Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation
Condition: Heart Defects, Congenital
Date: 2015-05-14
Interventions: Drug: Dexrazoxane Dose escalation every 4 subjects from 200mg/m2/dose; 300mg/m2/dose to 400mg/m2/dose
<<< Previous | Next >>>